Idiotypic networks and their possible exploitation for manipulation of the immune response. 1981

I M Roitt, and A Cooke, and D K Male, and F C Hay, and G Guarnotta, and P M Lydyard, and L P de Carvalho, and Y Thanavala, and J Ivanyi

UI MeSH Term Description Entries
D007130 Immunoglobulin Idiotypes Unique genetically-controlled determinants present on ANTIBODIES whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the IMMUNOGLOBULIN VARIABLE REGION of both immunoglobin polypeptide chains. Idiotypes, Immunoglobulin,Ig Idiotypes,Idiotype, Ig,Idiotype, Immunoglobulin,Idiotypes, Ig,Ig Idiotype,Immunoglobulin Idiotype
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008211 Lymphocyte Cooperation T-cell enhancement of the B-cell response to thymic-dependent antigens. Cooperation, Lymphocyte,Cooperations, Lymphocyte,Lymphocyte Cooperations
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000888 Antibodies, Anti-Idiotypic Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies. Anti-Antibodies,Anti-Idiotype Antibodies,Antibodies, Internal Image,Antigamma Globulin Antibodies,Antiglobulins,Anti Antibodies,Anti-gamma Globulin Antibodies,Anti Idiotype Antibodies,Anti gamma Globulin Antibodies,Anti-Idiotypic Antibodies,Antibodies, Anti,Antibodies, Anti Idiotypic,Antibodies, Anti-Idiotype,Antibodies, Anti-gamma Globulin,Antibodies, Antigamma Globulin,Globulin Antibodies, Anti-gamma,Globulin Antibodies, Antigamma,Image Antibodies, Internal,Internal Image Antibodies
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000916 Antibody Diversity The phenomenon of immense variability characteristic of ANTIBODIES. It enables the IMMUNE SYSTEM to react specifically against the essentially unlimited kinds of ANTIGENS it encounters. Antibody diversity is accounted for by three main theories: (1) the Germ Line Theory, which holds that each antibody-producing cell has genes coding for all possible antibody specificities, but expresses only the one stimulated by antigen; (2) the Somatic Mutation Theory, which holds that antibody-producing cells contain only a few genes, which produce antibody diversity by mutation; and (3) the Gene Rearrangement Theory, which holds that antibody diversity is generated by the rearrangement of IMMUNOGLOBULIN VARIABLE REGION gene segments during the differentiation of the ANTIBODY-PRODUCING CELLS. Germ Line Theory,Antibody Diversities,Diversities, Antibody,Diversity, Antibody,Germ Line Theories,Theories, Germ Line,Theory, Germ Line

Related Publications

I M Roitt, and A Cooke, and D K Male, and F C Hay, and G Guarnotta, and P M Lydyard, and L P de Carvalho, and Y Thanavala, and J Ivanyi
April 1986, Immunological reviews,
I M Roitt, and A Cooke, and D K Male, and F C Hay, and G Guarnotta, and P M Lydyard, and L P de Carvalho, and Y Thanavala, and J Ivanyi
January 1981, Contemporary topics in molecular immunology,
I M Roitt, and A Cooke, and D K Male, and F C Hay, and G Guarnotta, and P M Lydyard, and L P de Carvalho, and Y Thanavala, and J Ivanyi
December 1988, Journal of neuroimmunology,
I M Roitt, and A Cooke, and D K Male, and F C Hay, and G Guarnotta, and P M Lydyard, and L P de Carvalho, and Y Thanavala, and J Ivanyi
May 1985, Revue francaise de transfusion et immuno-hematologie,
I M Roitt, and A Cooke, and D K Male, and F C Hay, and G Guarnotta, and P M Lydyard, and L P de Carvalho, and Y Thanavala, and J Ivanyi
July 1978, European journal of immunology,
I M Roitt, and A Cooke, and D K Male, and F C Hay, and G Guarnotta, and P M Lydyard, and L P de Carvalho, and Y Thanavala, and J Ivanyi
January 1979, Annales d'immunologie,
I M Roitt, and A Cooke, and D K Male, and F C Hay, and G Guarnotta, and P M Lydyard, and L P de Carvalho, and Y Thanavala, and J Ivanyi
September 2012, Methods (San Diego, Calif.),
I M Roitt, and A Cooke, and D K Male, and F C Hay, and G Guarnotta, and P M Lydyard, and L P de Carvalho, and Y Thanavala, and J Ivanyi
December 2007, IEEE transactions on systems, man, and cybernetics. Part B, Cybernetics : a publication of the IEEE Systems, Man, and Cybernetics Society,
I M Roitt, and A Cooke, and D K Male, and F C Hay, and G Guarnotta, and P M Lydyard, and L P de Carvalho, and Y Thanavala, and J Ivanyi
June 1973, Pharmacological reviews,
I M Roitt, and A Cooke, and D K Male, and F C Hay, and G Guarnotta, and P M Lydyard, and L P de Carvalho, and Y Thanavala, and J Ivanyi
January 1989, Progress in clinical and biological research,
Copied contents to your clipboard!